| Dr Jerry S Fagelman, MD | |
|
39400 Garfield Rd, Suite 103, Clinton Township, MI 48038-4096 | |
| (586) 286-6550 | |
| (586) 286-1843 |
| Full Name | Dr Jerry S Fagelman |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 39400 Garfield Rd, Clinton Township, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184799058 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | JF025417 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jerry S Fagelman, MD 39400 Garfield Rd, Suite 103, Clinton Township, MI 48038-4096 Ph: (586) 286-6550 | Dr Jerry S Fagelman, MD 39400 Garfield Rd, Suite 103, Clinton Township, MI 48038-4096 Ph: (586) 286-6550 |
News Archive
Studying just eight families worldwide, the international team of researchers have discovered a genetic defect that results in profound depression and parkinsonism in a disorder known as Perry syndrome.
An international team including researchers from MIPT's Laboratory for Advanced Studies of Membrane Proteins have proposed an explanation of the way bacteria process external signals.
NeuroSigma, Inc., a Los Angeles-based medical technology company, announced today that it has signed a contract with the University of California, Los Angeles (UCLA) to fund a Phase I pediatric clinical trial to study the use of non-invasive, external Trigeminal Nerve Stimulation (TNS) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
Astellas Pharma Inc. announced that data from a Phase 2 study evaluating the investigational use of enzalutamide as a single agent for the treatment of advanced androgen receptor (AR) positive, triple-negative breast cancer (TNBC) were presented during an oral abstracts session at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
Early identification of adverse effects of drugs before they are tested in humans is crucial in developing new therapeutics, as unexpected effects account for a third of all drug failures during the development process.
› Verified 8 days ago
Dr. Robert J Franchi, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 37555 Garfield Rd, Suite 100, Clinton Township, MI 48036 Phone: 586-263-5000 Fax: 586-263-5009 | |
Dr. Robert G Mobley, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 42524 Hayes Rd, Suite 400, Clinton Township, MI 48038 Phone: 586-263-1168 Fax: 586-263-1169 | |
Dr. Nicholas Leone, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 39400 Garfield Rd, Suite 103, Clinton Township, MI 48038 Phone: 586-286-6550 Fax: 586-286-1843 | |
Steven W. Fite, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 16530 19 Mile Rd, Clinton Township, MI 48038 Phone: 586-226-2020 Fax: 586-286-0407 | |
Dr. John B Nori, DO Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 37555 Garfield Rd, Suite 100, Clinton Township, MI 48036 Phone: 586-263-5000 Fax: 586-263-5009 |